Lupin has received the Food and Drug Administration’s green light for rivaroxaban tablets, in 10 mg, 15 mg and 20 mg, which is the generic of Janssen’s Xarelto. This product will be ...

Bangalore: Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received approval for its Abbreviated New Drug Application (ANDA) for Rivaroxaban Tablets USP from the United States ...

The estimated market size for remaining strengths of Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg, is US$ 8,052 million for twelve months ending March 2025 according to IQVIA. Alembic has a ...

Lupin receives US FDA approval for rivaroxaban tablets USP, 10 mg, 15 mg & 20 mg: Our Bureau, Mumbai Thursday, May 15, 2025, 15:40 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced that it ...

X-VErT enrolled around 1,500 patients who were assigned to either Xarelto 20mg once-daily or a VKA (mainly warfarin) and found that compared to patients treated with Bayer and Janssen's drug had a ...

Generic Xarelto is a blood thinner medicine that lowers blood clotting. ... Aurobindo has obtained the Food and Drug Administration’s green light for rivaroxaban tablets, ... 15 mg and 20 mg.

In addition to the final approval for the 2.5mg dosage, Aurobindo has also secured tentative approvals from the USFDA for Rivaroxaban tablets in 10mg, 15mg, and 20mg strengths.

Aurobindo Pharma has received final USFDA approval to launch generic Rivaroxaban 2.5mg tablets in the US, ... 2.5mg — the generic equivalent of Janssen Pharmaceuticals’s blockbuster drug, Xarelto ...

Generic drugmaker Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg. The approved product ...

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, ... 15 mg and 20 mg tables, ... 2022, and May 31, 2023. Xarelto was part of the first list of ...

Xarelto is also available in 10mg, 15mg, and 20mg tablets, as well as an oral suspension (1mg/mL), to treat various conditions. Lupin is introducing rivaroxaban tablets, 2.5 mg to the market.